BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 29459868)

  • 1. Characteristics of Infection Immunity Regulated by
    Hwang YS; Shin JH; Yang JP; Jung BK; Lee SH; Shin EH
    Front Immunol; 2018; 9():158. PubMed ID: 29459868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 and Galectin-9 May Differently Regulate the Expressions of Microglial M1/M2 Markers and T Helper 1/Th2 Cytokines in the Brains of Genetically Susceptible C57BL/6 and Resistant BALB/c Mice Following Peroral Infection With
    Liu J; Huang S; Lu F
    Front Immunol; 2018; 9():1648. PubMed ID: 30108583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dectin-1-CD37 association regulates IL-6 expression during Toxoplasma gondii infection.
    Yan J; Wu B; Huang B; Huang S; Jiang S; Lu F
    Parasitol Res; 2014 Aug; 113(8):2851-60. PubMed ID: 24870248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
    Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
    J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system.
    Blanchard N; Dunay IR; Schlüter D
    Parasite Immunol; 2015 Mar; 37(3):150-8. PubMed ID: 25573476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression.
    Angeloni MB; Guirelli PM; Franco PS; Barbosa BF; Gomes AO; Castro AS; Silva NM; Martins-Filho OA; Mineo TW; Silva DA; Mineo JR; Ferro EA
    Placenta; 2013 Nov; 34(11):973-82. PubMed ID: 24074900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
    Kang H; Remington JS; Suzuki Y
    J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.
    Sa Q; Ochiai E; Tiwari A; Perkins S; Mullins J; Gehman M; Huckle W; Eyestone WH; Saunders TL; Shelton BJ; Suzuki Y
    J Immunol; 2015 Aug; 195(3):796-800. PubMed ID: 26091720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
    Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
    J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial STAT1-sufficiency is required for resistance to toxoplasmic encephalitis.
    Cowan MN; Kovacs MA; Sethi I; Babcock IW; Still K; Batista SJ; O'Brien CA; Thompson JA; Sibley LA; Labuzan SA; Harris TH
    PLoS Pathog; 2022 Sep; 18(9):e1010637. PubMed ID: 36067217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes, microglia/macrophages, and neurons expressing Toll-like receptor 11 contribute to innate immunity against encephalitic Toxoplasma gondii infection.
    Atmaca HT; Kul O; Karakuş E; Terzi OS; Canpolat S; Anteplioğlu T
    Neuroscience; 2014 Jun; 269():184-91. PubMed ID: 24704432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.
    Torres M; Guiton R; Lacroix-Lamandé S; Ryffel B; Leman S; Dimier-Poisson I
    J Neuroinflammation; 2013 Feb; 10():19. PubMed ID: 23374751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Toxoplasma gondii infection on the brain.
    Carruthers VB; Suzuki Y
    Schizophr Bull; 2007 May; 33(3):745-51. PubMed ID: 17322557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-γ-dependent manner.
    French T; Düsedau HP; Steffen J; Biswas A; Ahmed N; Hartmann S; Schüler T; Schott BH; Dunay IR
    J Neuroinflammation; 2019 Jul; 16(1):159. PubMed ID: 31352901
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Shinjyo N; Hikosaka K; Kido Y; Yoshida H; Norose K
    Front Immunol; 2020; 11():603924. PubMed ID: 33613523
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.